Apheresis Market

Apheresis Market Size (2023 to 2028)

The global apheresis market size is estimated to grow to USD 3.88 billion by 2028 from USD 2.41 billion in 2023, showcasing a CAGR of 9.96% during the forecast period. 

MARKET DRIVERS:

The growing patient population of chronic diseases majorly drives the growth of the apheresis market. Apheresis procedures have observed a rise in the number and areas of applications in recent years and the apheresis market for these procedures continues to increase at an unprecedented pace. Currently, apheresis procedures are used to treat various chronic diseases such as renal diseases, neurology, cancer, hematology, autoimmune diseases, and cardiovascular diseases. Several private and public insurers have begun to observe the apheresis reimbursement procedure. Many private insurers cover apheresis procedures regardless of whether they are conducted in a hospital. Similar policy-related reforms are implemented in other countries and insurers have a consensus on wide coverage of diseases. Apheresis helps significantly in controlling disease progression, reducing disease-related complications, and improving the quality of life for patients.

The growing demand for blood components and plasma derivatives in therapeutic treatments, the increasing geriatric population prone to age-related conditions requiring apheresis procedures, the growing number of advancements in apheresis technology and an increasing number of organ transplant procedures create the need for apheresis in pre-transplant and post-transplant treatments propel the apheresis market growth. The expansion of the plasma collection industry, increasing demand for plasma-derived therapies, rising awareness about the benefits of apheresis procedures among healthcare professionals and patients and growing research and development activities in the field of apheresis and related therapeutic applications contribute to the apheresis market growth.

The expansion of healthcare infrastructure, rising healthcare expenditure in developing economies, an increasing number of blood banks and blood donation centers, favorable reimbursement policies for apheresis procedures in several countries and the growing number of collaborations and partnerships between medical device manufacturers and healthcare institutions support the apheresis market growth. The growing demand for personalized medicine and targeted therapies, rapid adoption of apheresis procedures in the treatment of hematological disorders, rising prevalence of chronic kidney disease, rising need for renal replacement therapies, technological advancements in automated apheresis systems that reduce the procedure time and improve patient comfort support the market growth. The growing prevalence of cardiovascular diseases and demand for lipid-lowering therapies, increasing demand for therapeutic apheresis in the management of neurological and autoimmune disorders and strong support from government organizations and regulatory bodies for the development and adoption of apheresis technologies fuel the growth rate of the apheresis market.

MARKET RESTRAINTS:

Limited availability of skilled healthcare professionals trained in apheresis procedures, high cost associated with apheresis treatments and equipment and stringent regulatory requirements and approval processes for apheresis procedures and devices hamper the apheresis market growth. Potential risks and complications associated with apheresis, such as infection, allergic reactions, and vascular access-related issues, limited awareness and understanding of apheresis procedures among healthcare providers and patients and challenges in maintaining a steady supply of donor blood or other necessary components for apheresis procedures further inhibit the growth rate of the apheresis market. Lack of standardized guidelines and protocols for apheresis treatments, leading to variations in practice, limited reimbursement coverage for apheresis procedures, impacting affordability for patients and financial viability for healthcare providers and the competition from alternative treatment options and therapies for the same indications as apheresis further limits the growth rate of the apheresis market.

Impact of COVID-19 on the global apheresis market:

The outrage over the recent coronavirus (COVID-19) has led to significant and rapid healthcare industry changes. The World Health Organization (WHO) announced the pandemic as public health emergency issue. Many hospitals and clinics have shut their doors temporarily during the lockdown period. The medical professionals on the front line battling COVID-19 must take precautionary measures to prevent the disease's spread. COVID-19 has negatively impacted the apheresis market growth during the first half of the pandemic. Amidst the crisis, none of the patients have visited the hospitals and clinics to be safe and protect themselves from the virus. The professionals have taken severe measures to collect any blood components from patients or donors to avoid infection. Healthcare professionals have re-started their work organizing blood from the patients or donors that may be used during emergencies. The growth of the global apheresis market is expected to pick the pace up owing to the resuming of activities by performing surgical procedures. In addition, considering the reduced impact of COVID-19 and growing habituation towards the new normalization, the apheresis market is anticipated to showcase a healthy growth rate during the forecast period.

REPORT COVERAGE:

This research report on the global apheresis market has been segmented and sub-segmented into the following categories.

Apheresis Market - By Product:

• Devices
• Disposables

Based on the product, the disposable segment is predicted to lead the global apheresis market during the forecast period owing to the growing demand for advanced and technologically sophisticated apheresis devices. The rising prevalence of chronic diseases and complex medical conditions requiring apheresis treatments and technological advancements in automated and portable apheresis devices further propel the growth of the disposable segment in the global apheresis market.

The devices segment is expected to capture a notable share of the global market during the forecast period. The growing adoption of apheresis procedures, increasing need for hygienic and sterile disposable components, convenience, cost-effectiveness and reduced risk of cross-contamination associated with disposable products further drive the growth of the devices segment in the global market.

Apheresis Market - By Procedure:

• Donor
• Therapeutic
• Photopheresis

Based on the procedure, the therapeutic apheresis segment is projected to register a healthy CAGR rate during the forecast period. Factors such as the growing prevalence of autoimmune diseases and hematological disorders requiring therapeutic apheresis, the increasing number of advancements in therapeutic apheresis techniques and procedures and rising demand for targeted and personalized treatments.

The plasmapheresis segment accounted for a considerable share of the global market in 2022 and is expected to continue holding a strong foothold in the coming years. The growing applications in the treatment of graft-versus-host disease (GVHD) and other immune-mediated disorders, the efficacy of photopheresis in modulating the immune response and improving patient outcomes and the rapid adoption of photopheresis in specialized healthcare settings drive the growth of the plasmapheresis segment in the global market.

Apheresis Market – By Application:

• Renal Diseases
• Neurology
• Cancer
• Hematology
• Autoimmune Diseases
• Cardiovascular Diseases

Based on the application, the neurology segment is expected to account for the largest share of the market during the forecast period. The growing incidence of neurological disorders such as multiple sclerosis, myasthenia gravis, and Guillain-Barré syndrome, the effectiveness of apheresis in removing harmful antibodies and autoantibodies from the bloodstream and the rising focus on precision medicine and personalized treatment approaches in neurology propel the growth of the neurology segment.

The hematology segment is estimated to grow at the fastest CAGR during the forecast period in the global market owing to the growing prevalence of hematological disorders such as leukemia, lymphoma, and thrombocytopenia. The rising demand for blood component therapies and stem cell transplantation and an increasing number of advancements in apheresis technology and its role in the treatment of hematological conditions drive the growth of the hematology segment in the worldwide market.

Apheresis Market – By Technology:

• Centrifuge
• Membrane Separation

Based on the technology, the centrifuge apheresis segment is the most lucrative. The primary usage of centrifuges majorly drives this segment's growth for the preparation of blood components such as packed red blood cells and fresh frozen plasma.

The membrane separation segment is expected to have rapid growth during the forecast period as it requires less time and prevents the lessening of blood coagulation factors, limiting the demand for replacement fluids.

Apheresis Market – By End User:

• Private Blood Collection Centres
• Public Blood Collection Centres
• Hospitals

Based on the end-user, the private and public blood collection centers segment is expected to dominate the market. The increasing number of blood component donations, growing blood centers, and raising awareness of blood collection are majorly supporting segmental growth.

Apheresis Market – By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Geographically, the apheresis market in North America outranked other regions and accounted for the major share of the global apheresis market in 2022. The domination of the North American region in the global market is anticipated to continue throughout the forecast period. The growing prevalence of chronic diseases, technological advancements in apheresis procedures and increasing demand for plasma and platelet products drive the growth of the North American market. The growing geriatric population, the presence of a well-established healthcare infrastructure and stringent regulatory guidelines for blood donation and transfusion further support the apheresis market in North America. The U.S. followed by Canada are predicted to hold the leading share of the North American market during the forecast period.

The Europe apheresis market is anticipated to hold a substantial share of the worldwide market during the forecast period owing to the rising demand for source plasma for fractionation, the growing incidence of autoimmune disorders and favorable reimbursement policies. The growing number of blood transfusion procedures, the increasing number of advancements in apheresis technologies and the rising number of collaborations between blood centers and hospitals drive the European market growth. The UK and Germany are expected to capture the major share of the European market in the coming years.

The apheresis market in Asia Pacific is the fastest-growing market because countries such as Japan and emerging economies such as India and China are projected to witness exponential growth during the forecast period. The growing awareness about blood and plasma donation, increasing number of improvements in the healthcare infrastructure and rising healthcare expenditure fuel the growth of the APAC market. The rising prevalence of blood disorders, the increasing number of initiatives from the governments of APAC countries to enhance blood safety and the rapid adoption of advanced apheresis devices further contribute to the APAC market growth. China, Japan and India are the major contributors to the APAC market.

The Latin American apheresis market is anticipated to grow at a steady CAGR during the forecast period owing to the growing number of healthcare facilities, rising prevalence of chronic diseases and increasing demand for plasma products. The growing number of initiatives from the governments of Latin American to enhance blood donation, the expansion of apheresis centers and rising medical tourism in the Latin American region contribute to the Latin American market growth. Brazil followed by Mexico are estimated to dominate the Latin American market during the forecast period.

The apheresis market in MEA is expected to hold a moderate share of the global market in the coming years owing to the growing prevalence of blood disorders, improving healthcare infrastructure and the growing number of initiatives from the governments of MEA countries for blood donation campaigns.

KEY MARKET PARTICIPANTS:

Some of the companies that are playing a dominating role in the global apheresis market profiled in the report are Asahi Kasei Medical Co., Ltd., Haemonetics Corporation, Terumo BCT, Inc., Fresenius Medical Care, Kawasumi Laboratories Inc., Cerus Corporation, HemaCare Corporation, Kaneka Corporation, B. Braun Melsungen AG, and Nikkiso Co., Ltd., Therakos, Inc., and Medica S.p.A.